AFG
RDY icon

Atomi Financial Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Atomi Financial Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,921
Closed -$165K – 1319
2026
Q1 		$165K Sell
11,921
-575
-5% -$8.01K 0.01% 1172
2025
Q4 		$175K Sell
12,496
-301
-2% -$4.22K 0.01% 1156
2025
Q3 		$179K Buy
12,797
+894
+8% +$12.9K 0.01% 1123
2025
Q2 		$179K Buy
+11,903
New +$170K 0.01% 1055
2025
Q1 		– Sell
-10,271
Closed -$162K – 1104
2024
Q4 		$162K Buy
+10,271
New +$154K 0.01% 932

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atomi Financial Group's RDY Position: Q2 2026 in Review

Atomi Financial Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 11,921 shares — an estimated $165K sold.

Atomi Financial Group first reported a position in RDY in Q4 2024 and held it in 5 quarters. The position peaked at $179K in Q3 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Atomi Financial Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Atomi Financial Group sold 11,921 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $165K.
  • Atomi Financial Group first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 5 quarters.
  • Atomi Financial Group's Dr. Reddy's Laboratories position peaked at $179K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.